Beyond Biotech - the podcast from Labiotech

1:03 Labiotech.eu news 2:34 Knowledge Gate 10:59 Janssen Scientific Affairs This week, our guests are Viktoriya Vasilenko, Knowledge Gate co-founder and CEO; and Avery Ince, vice president, medical affairs, cardiovascular & metabolism at Janssen Scientific Affairs. Study confirms benefit of XARELTO (rivaroxaban) for secondary prevention of venous thromboembolism in cancer patients The Janssen...

2:18 Labiotech.eu news 3: 46 Mainz Biomed 19:14 Newron This week, we have two guests. We have conversations with Newron Pharmaceuticals' CEO, Stefan Weber, and Mainz Biomed CEO, Guido Bächler. Mainz Biomed Provides Year-End 2022 Corporate Review Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced its corporate summary for the fis...

1:37 Labiotech.eu news 3:34 Cradle 19:47 Rani Therapeutics This week, we have two guests. We have conversations with Talat Imran, CEO of Rani Therapeutics; and Stef van Grieken, CEO and co-founder of Cradle. Rani Therapeutics - aiming to remove the pain of needles Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, has ann...

2:19 Labiotech.eu news 4:37 CellCentric 12:21 MicrofluidX 29:12 Potter Clarkson This week, we have three guests. We have conversations with Antoine Espinet, CEO of MicrofluidX; Will West, CEO of CellCentric; and Sara Holland, patent attorney at Potter Clarkson. MicrofluidX raises £3.3M to develop advanced therapy manufacturing platform MicrofluidX (MFX), a U.K. based provider of next-generation bi...

2:33 Labiotech.eu news 5:03 Humacyte 23:01 Transgene 37:21 Center for Global Development 54:32 JLL This week, we have three interviews. One is from Bio-Europe, a chat with Transgene chief business officer, Steven Bloom, and we also have conversations with Humacyte CEO Laura Niklason, and with Anthony McDonnell, Senior Policy Analyst at the Center for Global Development, on the subject of antimicro...

2:40 Labiotech.eu news 4:58 SOTIO Biotech 13:43 Eversana 19:37 Carl Borrebaeck 36:42 Concarlo Therapeutics This week, we have four interviews: Franjo Hanzl, vice president commercial development Europe at Eversana; Stacy Blain, founder and CEO of Concarlo Therapeutics; Jens Hennecke, chief business officer at SOTIO Biotech; and Carl Borrebaeck, chairman of the board of directors of Immunovia and p...

1:45 Labiotech.eu news 4:02 PsychoGenics 20:56 Destiny Pharma 36:30 QureTech Bio 54:41 AiCuris 70:45 JLL This week, we have three interviews on the theme of antimicrobial resistance (AMR), to mark World Antimicrobial Awareness Week. We spoke with Holger Zimmermann, CEO of anti-infectives company AiCuris; Neil Clark, CEO of Destiny Pharma, and Fredrik Almqvist, co-founder of QureTech Bio. We also h...

1:32 Labiotech.eu news 4:02 PacBio 34:02 Sierra Space 57:12 JLL This week, we have two longer interviews. We have conversations with Neil Ward, VP of PacBio EMEA, and Marc Giulianotti, senior manager in space biomanufacturing at Sierra Space. We also have our weekly contribution from global commercial real estate services company JLL , with Travis McCready.  Sierra Space and UC San Diego to develo...

1:41 Labiotech.eu news 4:17 Longevity Science Foundation 23:07 HTID 35:56 CanSinoBio 54:47 JLL This week, we have three interviews, and four guests. We chat with Pierre Corneille VP of the HTFC, which is responsible for HealthTech Innovation Days; Sergey Jakimov, co-founder and managing partner of LongeVC and the Longevity Science Foundation's CEO Lisa Ireland; and Pierre Morgon, executive vi...

5:33 e-therapeutics 21:25 BioWin  32:46 CMT Research Foundation 57:47 JLL This week, we have three interviews, and four guests. We chatted with Keith Fargo, chief scientific officer at the CMT Research Foundation; François Colery, head of the Talent Now initiative and Sylvie Ponchaut, managing director, from BioWin; and e-therapeutics’ CEO, Ali Mortazavi.  We also have our weekly contribution from...

2:22 Labiotech.eu news 4:53 TAU Systems 21:54 Bone Health Technologies  33:26 Immutep 44:36 JLL This week, we have conversations with Marc Voigt, CEO of Immutep; Manuel Hegelich, CEO of TAU Systems; and ​​Laura Yecies, CEO of Bone Health Technologies.  We also have our weekly chat with global commercial real estate services company JLL , with Travis McCready.  FDA fast tracks Immutep non-small cel...

2:08 Labiotech.eu news 4:42 Faron Pharmaceuticals 15:22 BiotechX 20:13 Cultivated Biosciences 26:26 EPFL This week, we have four interviews. Our guests are: Juho Jalkanen, COO of Faron Pharmaceuticals ; Ardemis Boghossian and Melania Reggente from the EPFL School of Basic Sciences in Switzerland; Tomas Turner, CEO and co-founder of Cultivated Biosciences ; and Joanna Magaji, conference manager for...

2:09 Labiotech.eu news 4:16 BIO-Europe (biosaxony) 13:54 BIO-Europe (EBD Group EU) 28:25 National Hemophilia Foundation 44:40 JLL This week, we have three interviews. Our guests are: Pam Putz, managing director of EBD Group EU; André Hofmann, CEO of biosaxony; and Kevin Mills, chief scientific officer at the National Hemophilia Foundation and Teri Willey, managing director of the National Hemophil...

3:00 News 5:04 Omnio 14:01 Adocia 24:28 Tridek-One 29:49 Phenomix Sciences 47:27 JLL This week, we have four guests: Olivier Soula, deputy-CEO and director of R&D at Adocia; Ulrika Norin, CEO of Omnio; Mark Bagnall, CEO of Phenomix Sciences; and Laurence de Schoulepnikoff, CEO of Tridek-One. We also have our weekly chat with global commercial real estate services company JLL , with Travis McCr...

02:17 Labiotech.eu news 04:59 TikoMed 09:20 Pleco Therapeutics 25:45 Cullinan Oncology/World Cancer Research Day 44:15 JLL This week’s podcast has three guests. In honor of World Cancer Research Day on September 24, we have an overview of cancer research with Nadim Ahmed, CEO of Cullinan Oncology; a chat with Ivo Timmermans, CEO of Pleco Therapeutics; and talk with Anders Kristensson, CEO of TikoM...

2:56 News 5:42 NLS Days - overview 17:42 NLS Days - NLSInvest 29:35 NLS Days - AstraZeneca 42:13 JLL Beyond Biotech Podcast 14: Nordic Life Science Days 2022 This week’s podcast is dedicated to Nordic Life Science Days, otherwise known as NLS Days .  This year’s version is an in-person event from September 28-29, at the Malmömässan in Malmö, Sweden. In our preview of NLS Days, which features sessi...

2:32 Labiotech.eu news 4:45 BioInnovation Institute 20:18 IASP 37:38 JLL This week’s guests on the podcast are Bobby Soni, chief business officer at the BioInnovation Institute, and Harriet Edwards, International Association of Science Parks (IASP) media and community manager. We also have our weekly chat with global commercial real estate services company JLL, and this week it is with Travis McCr...

2:48 Labiotech.eu news 5:22 Gate Neurosciences 16:18 3Brain 31:13 Oncolyze 50:22 JLL This week’s podcast guests are Mike McCully, CEO of Gate Neurosciences ; Steven Evans, CEO and co-founder of Oncolyze ; and Philipp Markolin, scientific marketing specialist at 3Brain . We also have our weekly chat with global commercial real estate services company JLL , and this week it’s a chat with  Amber Schi...

2:15 Labiotech.eu news 5:12 Phase Genomics 16:44 IRB Barcelona 29:37 Ilya Pharma 43:00 Krystal Biotech 53:54   JLL Our guests are Ilya Pharma CEO and co-founder Evelina Vågesjö and chief financial officer Oskar Lund; Miguel Martín-Álvarez, postdoctoral fellow in the cancer science unit at IRB Barcelona; Hubert Chen, head of clinical development at Krystal Biotech; and Ivan Liachko, CEO of Phase Ge...

This week our guests on the podcast are Xianghao Zuo, deputy director of R&D at Triastek; Endpoint Health CEO Jason Springs; and Andy Whiting, CEO of Nevrargenics. 2:15 News 4:28 Nevrargenics 22:26 Triastek 37:14 Endpoint Health Triastek and Lilly working together on 3D printing for drugs A new research collaboration between Chinese company Triastek, Inc. and Eli Lilly and Company will leverag...

This week's guests are ARCH Venture Partners’ managing director Kristina Burow; founder and CEO of Micropep Thomas Laurent; Kylie O’Keefe, SVP, commercial & corporate strategy at PTC Therapeutics, and Juan Carlos Jaramillo, chief medical officer of Valneva. 1:40 News 3:47 PTC 18:32 Micropep 33:01 Valneva 42:12 ARCH ARCH Venture Partners closes $2.97B biotech fund ARCH Venture Partners has...

This week’s podcast guests are Laura Fletcher, head of business development and strategic partnerships at Deep Science Ventures; Matthias Steger, CEO of Endogena Therapeutics; Rodolphe Besserve, CEO, and Georges Rawadi, chief of biotech studio development, at eureKARE; and Biotech Growth Trust portfolio manager, Geoff Hsu. News: 02:30 Endogena Therapeutics 5:10 eureKARE 21:00 Deep Science Ventures...

This week's podcast features three interviews related to hepatitis. Our guests are Ahmed Elsharkawy, consultant transplant hepatologist and honorary senior clinical lecturer at the University of Birmingham in the UK; Ziv Ben-Ari, director of the Liver Diseases Center at the Sheba Medical Center in Israel, and James McIlroy, chief executive officer at EnteroBiotix. World Hepatitis Day Taking p...

On this week’s podcast, our guests are Jeremy Skillington, CEO of Poolbeg Pharma; Dani Bach, and Eric Moessinger, both partners at +ND Capital; and Louise Modis, chief scientific officer at Mogrify. Poolbeg Pharma , a clinical stage infectious disease pharmaceutical company, has received ethics and competent authority approval to commence its lipopolysaccharide (LPS) human challenge clinical trial...

This week’s guests are Erik Buntinx, CEO and founder of ANeuroTech; Stephen J. Matlin, CEO of Life Length; and Kees Melief, chief scientific officer at ISA Pharmaceuticals. Sponsor Interested in sponsoring one or more episodes of the podcast? Learn more here ! Leave a review on Apple podcasts Reviews are hugely important because they help new people discover this podcast. If you enjoyed listening...